Andreas Schulze

9.4k total citations · 1 hit paper
139 papers, 5.5k citations indexed

About

Andreas Schulze is a scholar working on Clinical Biochemistry, Molecular Biology and Cell Biology. According to data from OpenAlex, Andreas Schulze has authored 139 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Clinical Biochemistry, 60 papers in Molecular Biology and 33 papers in Cell Biology. Recurrent topics in Andreas Schulze's work include Metabolism and Genetic Disorders (74 papers), Muscle metabolism and nutrition (26 papers) and Folate and B Vitamins Research (21 papers). Andreas Schulze is often cited by papers focused on Metabolism and Genetic Disorders (74 papers), Muscle metabolism and nutrition (26 papers) and Folate and B Vitamins Research (21 papers). Andreas Schulze collaborates with scholars based in Germany, Canada and United States. Andreas Schulze's co-authors include Stephan Urban, Ertan Mayatepek, Georg F. Hoffmann, Philippe Gripon, Martin Lindner, Dirk Kohlmüller, Markus Wyss, Robert Bals, A. Schieck and Walter Mier and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Andreas Schulze

136 papers receiving 5.4k citations

Hit Papers

Interim analyses of a first-in-human phase 1/2 mRNA trial... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Schulze Germany 43 2.2k 2.0k 1.0k 1.0k 789 139 5.5k
Fumio Endo Japan 39 2.0k 0.9× 1.2k 0.6× 477 0.5× 338 0.3× 456 0.6× 185 5.1k
Piero Rinaldo United States 54 4.9k 2.3× 5.3k 2.7× 799 0.8× 371 0.4× 1.4k 1.7× 193 9.6k
Arnold W. Strauss United States 58 6.4k 2.9× 3.4k 1.7× 1.1k 1.1× 868 0.8× 532 0.7× 220 10.5k
André B. P. Kuilenburg Netherlands 47 6.3k 2.9× 548 0.3× 1.1k 1.0× 348 0.3× 360 0.5× 277 10.1k
Barbara K. Burton United States 50 2.9k 1.3× 2.8k 1.4× 1.0k 1.0× 522 0.5× 1.3k 1.6× 248 7.7k
Gerard T. Berry United States 48 3.1k 1.4× 3.3k 1.6× 309 0.3× 513 0.5× 716 0.9× 213 7.1k
Dietrich Matern United States 47 3.5k 1.6× 3.5k 1.8× 632 0.6× 346 0.3× 1.1k 1.4× 180 6.7k
H. Wächter Austria 41 1.8k 0.8× 1.0k 0.5× 1.3k 1.3× 203 0.2× 315 0.4× 170 7.5k
Charles A. Stanley United States 71 5.0k 2.3× 3.3k 1.7× 816 0.8× 349 0.3× 646 0.8× 249 13.7k
Seiji Yamaguchi Japan 50 4.4k 2.0× 2.9k 1.5× 1.0k 1.0× 641 0.6× 929 1.2× 491 9.3k

Countries citing papers authored by Andreas Schulze

Since Specialization
Citations

This map shows the geographic impact of Andreas Schulze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Schulze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Schulze more than expected).

Fields of papers citing papers by Andreas Schulze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Schulze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Schulze. The network helps show where Andreas Schulze may publish in the future.

Co-authorship network of co-authors of Andreas Schulze

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Schulze. A scholar is included among the top collaborators of Andreas Schulze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Schulze. Andreas Schulze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fisher, Krishna J., Rupert Derler, Florian Sonntag, et al.. (2025). Polo-like kinase inhibitors increase AAV production by halting cell cycle progression. Molecular Therapy — Methods & Clinical Development. 33(1). 101412–101412. 1 indexed citations
2.
Koeberl, Dwight D., Andreas Schulze, Neal Sondheimer, et al.. (2024). Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature. 628(8009). 872–877. 55 indexed citations breakdown →
3.
Cameron, Jessie M., et al.. (2024). ACMG/AMP variant classification framework in arginase 1 deficiency: Implications for birth prevalence estimates and diagnostics. SHILAP Revista de lepidopterología. 2. 101815–101815. 1 indexed citations
4.
Patterson, Catherine, Stephanie So, Eva Mamak, et al.. (2024). Long‐term neurodevelopmental outcomes following liver transplantation for metabolic disease‐a single centre experience. Journal of Inherited Metabolic Disease. 48(1). e12785–e12785. 2 indexed citations
5.
Schreiber, John M., Wei-Liang Chen, John R. Barber, et al.. (2024). Unraveling the Link: Seizure Characteristics and Ammonia Levels in Urea Cycle Disorder During Hyperammonemic Crises. Pediatric Neurology. 159. 48–55.
6.
Schulze, Andreas, et al.. (2023). Long-Term Treatment of Lipoprotein Lipase Deficiency with Medium-Chain Triglyceride-Enriched Diet: A Case Series. Nutrients. 15(16). 3535–3535. 4 indexed citations
7.
Tropak, Michael B., et al.. (2023). Evidence of an intracellular creatine-sensing mechanism that modulates creatine biosynthesis via AGAT expression in human HAP1 cells. Scientific Reports. 13(1). 22392–22392. 5 indexed citations
8.
Schulze, Andreas & Pranesh Chakraborty. (2023). The Ontario Newborn Screening Program: A novel referral center model. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 66(11). 1205–1213. 2 indexed citations
9.
Tavares, Erika, Graeme Nimmo, Tara Paton, et al.. (2022). Deep intronic variant in MVK as a cause for mevalonic aciduria initially presenting as non‐syndromic retinitis pigmentosa. Clinical Genetics. 102(6). 524–529. 4 indexed citations
10.
Tran, Christel, Mehrdad Yazdanpanah, Lianna Kyriakopoulou, et al.. (2014). Stable isotope dilution microquantification of creatine metabolites in plasma, whole blood and dried blood spots for pharmacological studies in mouse models of creatine deficiency. Clinica Chimica Acta. 436. 160–168. 12 indexed citations
11.
Cameron, Jessie M., Valeriy Levandovskiy, Nevena MacKay, et al.. (2010). Complex V TMEM70 deficiency results in mitochondrial nucleoid disorganization. Mitochondrion. 11(1). 191–199. 35 indexed citations
12.
Bohne, Felix, Markus Chmielewski, Gregor Ebert, et al.. (2008). T Cells Redirected Against Hepatitis B Virus Surface Proteins Eliminate Infected Hepatocytes. Gastroenterology. 134(1). 239–247. 135 indexed citations
13.
Wyss, Markus, Olivier Braissant, Ivo Pischel, et al.. (2007). Creatine and Creatine Kinase in Health and Disease – A Bright Future Ahead?. PubMed. 46. 309–334. 39 indexed citations
14.
Hoffmann, Georg F., Martin Lindner, Andreas Schulze, et al.. (2004). Frequencies of inherited organic acidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany. European Journal of Pediatrics. 163(2). 76–80. 44 indexed citations
15.
Schulze, Andreas, Ertan Mayatepek, & Georg F. Hoffmann. (2002). Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria. Clinica Chimica Acta. 317(1-2). 27–37. 30 indexed citations
16.
Schulze, Andreas, et al.. (2002). Increased Levels of Antimicrobial Peptides in Tracheal Aspirates of Newborn Infants during Infection. American Journal of Respiratory and Critical Care Medicine. 165(7). 992–995. 205 indexed citations
17.
Schulze, Andreas, Yvonne Guillou, Françoise Baleux, et al.. (1995). Importance of Residues 2–9 in the Immunoreactivity, Subunit Interactions, and Activity of the β2 Subunit of Escherichia coli Tryptophan Synthase. Journal of Biological Chemistry. 270(9). 4255–4261. 7 indexed citations
18.
Schulze, Andreas, Robert Huber, Wolfram Bode, & Richard A. Engh. (1994). Structural aspects of serpin inhibition. FEBS Letters. 344(2-3). 117–124. 53 indexed citations
19.
Schulze, Andreas, et al.. (1992). Evidence for the extent of insertion of the active site loop of intact .alpha.1 proteinase inhibitor in .beta.-sheet A. Biochemistry. 31(33). 7560–7565. 63 indexed citations
20.
Schulze, Andreas, Robert Huber, Eric Degryse, Denis Speck, & Rainer Bischoff. (1991). Inhibitory activity and conformational transition of α1‐proteinase inhibitor variants. European Journal of Biochemistry. 202(3). 1147–1155. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026